Exchange: NASDAQ·Updated 06:38 PM EDT
CTOR logo

CTOR Citius Oncology Inc.

$0.7922
$0.0145
(1.86%)
Today
Closed $0.7922
$0.0022
(0.28%)
After Hours
Mkt Cap$72.31M
Vol13,951.00

About CTOR

Citius Oncology, Inc. is a biopharmaceutical company, which engages in developing and commercializing targeted oncology therapies. Its lead product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein, for the treatment of patients with persistent or recurrent CTCL, a rare form of non-Hodgkin lymphoma. The company was founded on March 1, 2021 and is headquartered in Cranford, NJ.
41

Bearish Sentiment

How do you feel about CTOR?

Advertisement|Remove ads.